Lisata Therapeutics, Inc. (LSTA)
NASDAQ: LSTA · Real-Time Price · USD
3.900
+0.190 (5.12%)
At close: Jan 21, 2025, 4:00 PM
2.690
-1.210 (-31.03%)
Pre-market: Jan 22, 2025, 8:53 AM EST
Lisata Therapeutics Employees
Lisata Therapeutics had 25 employees as of December 31, 2023. The number of employees decreased by 2 or -7.41% compared to the previous year.
Employees
25
Change (1Y)
-2
Growth (1Y)
-7.41%
Revenue / Employee
n/a
Profits / Employee
-$829,600
Market Cap
32.74M
Employees Chart
Related Stocks
Company Name | Employees |
---|---|
UnitedHealth Group | 440,000 |
Johnson & Johnson | 131,900 |
Thermo Fisher Scientific | 122,000 |
Abbott Laboratories | 114,000 |
AstraZeneca | 89,900 |
Novartis AG | 76,057 |
Merck & Co. | 72,000 |
Novo Nordisk | 64,319 |
LSTA News
- 7 days ago - Lisata Therapeutics to Present at the 2025 Sequire Investor Summit - GlobeNewsWire
- 6 weeks ago - Lisata Therapeutics Announces Completion of Enrollment in the CENDIFOX Trial - GlobeNewsWire
- 2 months ago - Lisata Therapeutics Wins 2024 BioTech Breakthrough Award for ‘Specialized BioTherapeutics Company of the Year' - GlobeNewsWire
- 2 months ago - Lisata Therapeutics, Inc. (LSTA) Q3 2024 Earnings Call Transcript - Seeking Alpha
- 2 months ago - Lisata Therapeutics Reports Third Quarter 2024 Financial Results and Provides Business Update - GlobeNewsWire
- 2 months ago - Lisata Therapeutics and Valo Therapeutics Announce Preclinical Research Collaboration - GlobeNewsWire
- 2 months ago - Lisata Therapeutics to Report Third Quarter 2024 Financial Results and Provide a Business Update on Tuesday, November 12, 2024 - GlobeNewsWire
- 2 months ago - Lisata Therapeutics to Participate in Upcoming November 2024 Industry and Investor Events - GlobeNewsWire